Fixation of oligosaccharides to a surface may increase the susceptibility to human parainfluenza virus 1, 2, or 3 hemagglutinin-neuraminidase

Journal of Virology

Volumn 85, Issue 23, 2011, Pages 12146-12159

  Tappert, Mary M ^a   Smith, David F ^b   Air, Gillian M ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCAN; GLYCOPROTEIN; HN PROTEIN; N ACETYLNEURAMINIC ACID; OLIGOSACCHARIDE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CARBOHYDRATE ANALYSIS; CELL SURFACE; ENZYME SPECIFICITY; ERYTHROCYTE; HUMAN; HUMAN CELL; INFLUENZA VIRUS A; LIGAND BINDING; MOLECULAR SIZE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARAINFLUENZA VIRUS 1; PARAINFLUENZA VIRUS 2; PARAINFLUENZA VIRUS 3; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CLEAVAGE; VIRUS ATTACHMENT;

AMINO ACID SEQUENCE; ANIMALS; CELL MEMBRANE; CHICKENS; ERYTHROCYTES; GLYCOSYLATION; HEMAGGLUTINATION TESTS; HEMAGGLUTININS; HUMANS; MICROARRAY ANALYSIS; MOLECULAR SEQUENCE DATA; NEURAMINIDASE; OLIGOSACCHARIDES; PARAINFLUENZA VIRUS 1, HUMAN; PARAINFLUENZA VIRUS 2, HUMAN; PARAINFLUENZA VIRUS 3, HUMAN; PHYLOGENY; POLYSACCHARIDES; RECEPTORS, CELL SURFACE; RECEPTORS, VIRUS; RESPIROVIRUS INFECTIONS; SEQUENCE HOMOLOGY, AMINO ACID; TURKEY;

HUMAN PARAINFLUENZA VIRUS 1; INFLUENZA A VIRUS; PARAINFLUENZA VIRUS;

EID: 81255123479     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05537-11     Document Type: Article

References (44)

1. Ah-Tye, C., S. Schwartz, K. Huberman, E. Carlin, and A. Moscona. 1999. Virus-receptor interactions of human parainfluenza viruses types 1, 2 and 3. Microb. Pathog. 27:329-336.
2. Alvarez, R. A., and O. Blixt. 2006. Identification of ligand specificities for glycan-binding proteins using glycan arrays. Methods Enzymol. 415:292-310.
3. Alymova, I. V., et al. 16 August 2011. Receptor-binding specificity of the human parainfluenza virus type 1 hemagglutinin-neuraminidase glycoprotein. Glycobiology. doi:10.1093/glycob/cwr112.
4. Amonsen, M., D. F. Smith, R. D. Cummings, and G. M. Air. 2007. Human parainfluenza viruses hPIV1 and hPIV3 bind oligosaccharides with α2-3-linked sialic acids that are distinct from those bound by H5 avian influenza virus hemagglutinin. J. Virol. 81:8341-8345.
5. Bousse, T., and T. Takimoto. 2006. Mutation at residue 523 creates a second receptor binding site on human parainfluenza virus type 1 hemagglutinin-neuraminidase protein. J. Virol. 80:9009-9016.
6. Burlak, C., L. M. Twining, and M. A. Rees. 2005. Terminal sialic acid residues on human glycophorin A are recognized by porcine kupffer cells. Transplantation 80:344-352.
7. Cole, G. A., et al. 1994. Analysis of the primary T-cell response to Sendai virus infection in C57BL/6 mice: CD4+ T-cell recognition is directed predominantly to the hemagglutinin-neuraminidase glycoprotein. J. Virol. 68: 6863-6870.
8. Corpet, F. 1988. Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res. 16:10881-10890.
9. Crennell, S., T. Takimoto, A. Portner, and G. Taylor. 2000. Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase. Nat. Struct. Biol. 7:1068-1074.
10. Ferreira, L., E. Villar, and I. Munoz-Barroso. 2004. Gangliosides and N-glycoproteins function as Newcastle disease virus receptors. Int. J. Biochem. Cell Biol. 36:2344-2356.
11. Green, E. D., G. Adelt, J. U. Baenziger, S. Wilson, and H. Van Halbeek. 1988. The asparagine-linked oligosaccharides on bovine fetuin. Structural analysis of N-glycanase-released oligosaccharides by 500-megahertz 1H NMR spectroscopy. J. Biol. Chem. 263:18253-18268.
12. Greengard, O., N. Poltoratskaia, E. Leikina, J. Zimmerberg, and A. Moscona. 2000. The anti-influenza virus agent 4-GU-DANA (zanamivir) inhibits cell fusion mediated by human parainfluenza virus and influenza virus HA. J. Virol. 74:11108-11114.
13. Henrickson, K. J., and L. L. Savatski. 1997. Antigenic structure, function, and evolution of the hemagglutinin-neuraminidase protein of human parainfluenza virus type 1. J. Infect. Dis. 176:867-875.
14. Henrickson, K. J., and L. L. Savatski. 1992. Genetic variation and evolution of human parainfluenza virus type 1 hemagglutinin neuraminidase: analysis of 12 clinical isolates. J. Infect. Dis. 166:995-1005.
15. Henrickson, K. J., and L. L. Savatski. 1996. Two distinct human parainfluenza virus type 1 genotypes detected during the 1991 Milwaukee epidemic. J. Clin. Microbiol. 34:695-700.
16. Hermentin, P., et al. 1992. The mapping by high-pH anion-exchange chromatography with pulsed amperometric detection and capillary electrophoresis of the carbohydrate moieties of human plasma alpha 1-acid glycoprotein. Anal. Biochem. 206:419-429.
17. Hetherington, S. V., A. S. Watson, R. A. Scroggs, and A. Portner. 1994. Human parainfluenza virus type 1 evolution combines cocirculation of strains and development of geographically restricted lineages. J. Infect. Dis. 169:248-252.
18. Huberman, K., R. W. Peluso, and A. Moscona. 1995. Hemagglutinin-neuraminidase of human parainfluenza 3: role of the neuraminidase in the viral life cycle. Virology 214:294-300.
19. Iorio, R. M., et al. 2001. Structural and functional relationship between the receptor recognition and neuraminidase activities of the Newcastle disease virus hemagglutinin-neuraminidase protein: receptor recognition is dependent on neuraminidase activity. J. Virol. 75:1918-1927.
20. Lawrence, M. C., et al. 2004. Structure of the haemagglutinin-neuraminidase from human parainfluenza virus type III. J. Mol. Biol. 335:1343-1357.
21. Lyn, D., M. B. Mazanec, J. G. Nedrud, and A. Portner. 1991. Location of amino acid residues important for the structure and biological function of the haemagglutinin-neuraminidase glycoprotein of Sendai virus by analysis of escape mutants. J. Gen. Virol. 72:817-824.
22. Mahon, P. J., R. Deng, A. M. Mirza, and R. M. Iorio. 1995. Cooperative neuraminidase activity in a paramyxovirus. Virology 213:241-244.
23. Mahon, P. J., A. M. Mirza, T. A. Musich, and R. M. Iorio. 2008. Engineered intermonomeric disulfide bonds in the globular domain of Newcastle disease virus hemagglutinin-neuraminidase protein: implications for the mechanism of fusion promotion. J. Virol. 82:10386-10396.
24. Merz, D. C., P. Prehm, A. Scheid, and P. W. Choppin. 1981. Inhibition of the neuraminidase of paramyxoviruses by halide ions: a possible means of modulating the two activities of the HN protein. Virology 112:296-305.
25. Moscona, A., and R. W. Peluso. 1992. Fusion properties of cells infected with human parainfluenza virus type 3: receptor requirements for viral spread and virus-mediated membrane fusion. J. Virol. 66:6280-6287.
26. Moscona, A., and R. W. Peluso. 1991. Fusion properties of cells persistently infected with human parainfluenza virus type 3: participation of hemagglutinin-neuraminidase in membrane fusion. J. Virol. 65:2773-2777.
27. Palermo, L. M., et al. 2009. Human parainfluenza virus infection of the airway epithelium: viral hemagglutinin-neuraminidase regulates fusion protein activation and modulates infectivity. J. Virol. 83:6900-6908.
28. Porotto, M., M. Fornabaio, G. E. Kellogg, and A. Moscona. 2007. A second receptor binding site on human parainfluenza virus type 3 hemagglutinin-neuraminidase contributes to activation of the fusion mechanism. J. Virol. 81:3216-3228.
29. Porotto, M., M. Murrell, O. Greengard, L. Doctor, and A. Moscona. 2005. Influence of the human parainfluenza virus 3 attachment protein's neuraminidase activity on its capacity to activate the fusion protein. J. Virol. 79:2383-2392. VOL. 85, 2011 HN PREFERS SUBSTRATES ON A SURFACE 12159
30. Portner, A., R. A. Scroggs, P. S. Marx, and D. W. Kingsbury. 1975. A temperature-sensitive mutant of Sendai virus with an altered hemagglutinin-neuraminidase polypeptide: consequences for virus assembly and cytopathology. Virology 67:179-187.
31. Potier, M., L. Mameli, M. Belisle, L. Dallaire, and S. B. Melancon. 1979. Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl- alpha-D-N-acetylneuraminate) substrate. Anal. Biochem. 94:287-296.
32. Ryan, C., et al. 2006. Structural analysis of a designed inhibitor complexed with the hemagglutinin-neuraminidase of Newcastle disease virus. Glycoconj. J. 23:135-141.
33. Schonfeld, D. L., R. B. Ravelli, U. Mueller, and A. Skerra. 2008. The 1.8-A crystal structure of alpha1-acid glycoprotein (Orosomucoid) solved by UV RIP reveals the broad drug-binding activity of this human plasma lipocalin. J. Mol. Biol. 384:393-405.
34. Smith, G. W., and L. E. Hightower. 1983. Biological consequences of neuraminidase deficiency in Newcastle disease virus. J. Virol. 47:385-391.
35. Smith, G. W., and L. E. Hightower. 1982. Revertant analysis of a temperature-sensitive mutant of Newcastle disease virus with defective glycoproteins: implication of the fusion glycoprotein in cell killing and isolation of a neuraminidase-deficient hemagglutinating virus. J. Virol. 42:659-668.
36. Spiro, R. G. 1960. Studies on fetuin, a glycoprotein of fetal serum. I. Isolation, chemical composition, and physiochemical properties. J. Biol. Chem. 235:2860-2869.
37. Spiro, R. G., and V. D. Bhoyroo. 1974. Structure of the O-glycosidically linked carbohydrate units of fetuin. J. Biol. Chem. 249:5704-5717.
38. Spriggs, M. K., B. R. Murphy, G. A. Prince, R. A. Olmsted, and P. L. Collins. 1987. Expression of the F and HN glycoproteins of human parainfluenza virus type 3 by recombinant vaccinia viruses: contributions of the individual proteins to host immunity. J. Virol. 61:3416-3423.
39. Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680.
40. Wang, Z., and R. M. Iorio. 1999. Amino acid substitutions in a conserved region in the stalk of the Newcastle disease virus HN glycoprotein spike impair its neuraminidase activity in the globular domain. J. Gen. Virol. 80:749-753.
41. Warren, L. 1959. The thiobarbituric acid assay of sialic acids. J. Biol. Chem. 234:1971-1975.
42. Yamashita, K., T. Ohkura, H. Ideo, K. Ohno, and M. Kanai. 1993. Electrospray ionization-mass spectrometric analysis of serum transferrin isoforms in patients with carbohydrate-deficient glycoprotein syndrome. J. Biochem. 114:766-769.
43. Yuan, P., et al. 2005. Structural studies of the parainfluenza virus 5 hemag-glutinin-neuraminidase tetramer in complex with its receptor, sialyllactose. Structure 13:803-815.
44. Zaitsev, V., et al. 2004. Second sialic acid binding site in Newcastle disease virus hemagglutinin-neuraminidase: implications for fusion. J. Virol. 78: 3733-3741.